Trials / Unknown
UnknownNCT04374084
Moxibustion Plus Cupping in Convalescent Patients With COVID-19
Moxibustion Plus Cupping in Convalescent Patients With COVID-19: A Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.
Detailed description
Moxibustion plus cupping may be effective and safe for convalescent patients with COVID-19, but evidence is limited. The randomized clinical trial may help to provide evidence-based factors for improving the patients' symptoms in the convalescence of COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Moxibustion plus Cupping | Moxibustion: The burning of a small, thimble sized, smoldering plug of dried leaves on the skin at an acupuncture point. Usually the plugs contain leaves of mugwort or moxa. Cupping takes the pot as a tool, uses the combustion to remove the air in the pot, causes a negative pressure, and makes it adsorb on the skin of the acupoints. Use"Baixiaojiu"moxibustion on each acupoint for 10-15 minutes, the temperature of moxibustion should be adjusted within patient's tolerance level. Use diameter of 5-6 cm acuum cupper to cupping on each acupoint for 5-8 minutes. |
Timeline
- Start date
- 2020-05-10
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2020-05-05
- Last updated
- 2021-11-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04374084. Inclusion in this directory is not an endorsement.